We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SHL market cap is 58.25B. The company's latest EPS is EUR 1.3481 and P/E is 35.06.
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 14.52B | 14.46B | 18B | 21.71B | 21.68B |
| Operating Income | 2.3B | 1.98B | 2.57B | 2.93B | 2.14B |
| Net Income | 1.57B | 1.41B | 1.73B | 2.04B | 1.51B |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 21.43B | 25.09B | 42.16B | 49.06B | 46.68B |
| Total Liabilities | 11.65B | 12.58B | 25.82B | 29.2B | 28.55B |
| Total Equity | 9.78B | 12.51B | 16.34B | 19.85B | 18.13B |
| Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 1.62B | 1.93B | 2.93B | 2.5B | 2.12B |
| Investing | -647M | -1.91B | -14.14B | -868M | -1.07B |
| Financing | -603M | -249M | 11.84B | -1.64B | -690M |
| Market Cap | 58.25B |
| Price to Earnings Ratio | 35.06 |
| Price to Sales Ratio | 2.44 |
| Price to Cash Ratio | 32.22 |
| Price to Book Ratio | 2.92 |
| Dividend Yield | 1.83% |
| Shares Outstanding | 1.12B |
| Average Volume (1 week) | 15.33k |
| Average Volume (1 Month) | 17.82k |
| 52 Week Change | -7.60% |
| 52 Week High | 58.14 |
| 52 Week Low | 44.38 |
| Spread (Intraday) | 0.3 (0.57%) |
| Company Name | Siemens Healthineers AG |
| Address |
henkestrasse 127 erlangen 91052 |
| Website | https://www.siemens-healthineers.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
